We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NABL icon
11826
PUT
N-able
NABL
$792M
$138K ﹤0.01%
+12,400
New +$153K
CSCI
11827
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$138K ﹤0.01%
3,872
-254
-6% -$13.4K
CVT
11828
CALL
DELISTED
Cvent Holding Corp. Common Stock
CVT
$138K ﹤0.01%
+16,900
New +$138K
SBM
11829
DELISTED
ProShares Short Basic Materials
SBM
$138K ﹤0.01%
+2,982
New +$146K
AMSC icon
11830
PUT
American Superconductor
AMSC
$1.38B
$137K ﹤0.01%
12,600
-2,600
-17% -$37.5K
FBRX icon
11831
PUT
Forte Biosciences
FBRX
$137K ﹤0.01%
2,560
-8,020
-76% -$539K
REK icon
11832
ProShares Short Real Estate
REK
$11.9M
$137K ﹤0.01%
8,642
-12,129
-58% -$207K
STR
11833
PUT
DELISTED
Sitio Royalties
STR
$137K ﹤0.01%
+7,050
New +$150K
TK icon
11834
CALL
Teekay
TK
$1.14B
$137K ﹤0.01%
43,700
+33,500
+328% +$116K
UXIN
11835
PUT
Uxin Ltd
UXIN
$255M
$137K ﹤0.01%
870
-322
-27% -$69.2K
VKTX icon
11836
PUT
Viking Therapeutics
VKTX
$3.75B
$137K ﹤0.01%
29,800
-40,400
-58% -$226K
KBNT
11837
DELISTED
Kubient, Inc. Common Stock
KBNT
$137K ﹤0.01%
45,458
+20,949
+85% +$62.4K
IS
11838
CALL
DELISTED
ironSource Ltd.
IS
$137K ﹤0.01%
17,700
-26,900
-60% -$265K
HAAC
11839
PUT
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$137K ﹤0.01%
+14,000
New +$137K
AXGN icon
11840
Axogen
AXGN
$2.77B
$136K ﹤0.01%
+14,555
New +$175K
PHUN icon
11841
PUT
Phunware
PHUN
$42.8M
$136K ﹤0.01%
+1,036
New +$159K
PLYA
11842
DELISTED
Playa Hotels & Resorts
PLYA
$136K ﹤0.01%
17,060
-3,132
-16% -$25.1K
CO
11843
DELISTED
Global Cord Blood Corporation
CO
$136K ﹤0.01%
32,452
+603
+2% +$2.56K
ICAD
11844
PUT
DELISTED
iCAD Inc
ICAD
$135K ﹤0.01%
18,700
-31,800
-63% -$284K
NL icon
11845
CALL
NLI Holdings
NL
$329M
$135K ﹤0.01%
+18,200
New +$118K
OII icon
11846
PUT
Oceaneering
OII
$5.04B
$135K ﹤0.01%
11,900
-800
-6% -$10.4K
OXSQ icon
11847
Oxford Square Capital
OXSQ
$146M
$135K ﹤0.01%
33,003
-22,880
-41% -$95.2K
TBPH icon
11848
CALL
Theravance Biopharma
TBPH
$885M
$135K ﹤0.01%
12,200
-192,200
-94% -$1.68M
ZETA icon
11849
PUT
Zeta Global
ZETA
$7.67B
$135K ﹤0.01%
+16,000
New +$134K
RPT
11850
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$135K ﹤0.01%
+10,127
New +$136K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.